The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients

Published:2023-07-31 Issue: Volume: Page:
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Otten Antonius T¹^ORCID,Dijkstra Gerard¹,Visschedijk Marijn C¹,Bourgonje Arno R¹²

Affiliation:

1. Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen , Groningen , the Netherlands

2. The Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai , New York, NY , USA

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

https://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izad144/51012623/izad144.pdf

Reference9 articles.

1. Therapeutic drug monitoring 2.0: Time to assemble the puzzle;Wang;Inflamm Bowel Dis.,2023

2. Clinical validation of a capillary blood home-based self-sampling technique for monitoring of infliximab, vedolizumab, and C-reactive protein concentrations in patients with inflammatory bowel disease;Otten;Inflamm Bowel Dis.,2023

3. Effect of therapeutic drug monitoring vs standard therapy during maintenance infliximab therapy on disease control in patients with immune-mediated inflammatory diseases: a randomized clinical trial;Syversen;JAMA.,2021

4. Multi-model averaging improves the performance of modelguided infliximab dosing in patients with inflammatory bowel diseases;Kantasiripitak;CPT Pharmacometrics Syst Pharmacol,2022

5. Higher postinduction infliximab serum trough levels are associated with healing of fistulizing perianal Crohn’s disease in children;El-Matary;Inflamm Bowel Dis.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3